Transgenic Animal Immunization

Transgenic Animal Immunization

Discovery Services

Information

Currently, multiple transgenic animal strains and species (mice, rats, chicken) are offered to directly generate human antibodies in an animal, eliminating the necessity to humanize the resulting product. At ImmunoPrecise, we are proud to have worked with most of the globally available transgenic animals for our clients and partners. We have optimized our suite of services to these animals and applied our hybridoma, B cell Select, and phage display technologies successfully.
Link
https://www.immunoprecise.com/end-to-end-services/immunization/
ImmunoPrecise AntibodiesImmunoPrecise is an international, full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell SelectTM progressive, single-cell interrogation technology and the DeepDisplayTM custom phage libraries, as well as the AbthenaTM bispecific program. IPA is focused on the next generation of antibody discovery, to deliver the most therapeutically relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials. ImmunoPrecise’s discovery and development are conducted in Utrecht and Oss, the Netherlands (U-Protein Express and IPA Europe, respectively), and in Victoria, British Columbia (IPA Canada). The Company operates globally to offer a continuum of superior antibody services, transforming the face of therapeutic discovery, by decreasing turnaround time and risk, and promoting clinical success.

Log in